Provided by Tiger Fintech (Singapore) Pte. Ltd.

Redhill Biopharma

2.75
-0.2612-8.68%
Volume:1.12M
Turnover:3.03M
Market Cap:3.52M
PE:-0.07
High:2.85
Open:2.85
Low:2.60
Close:3.01
Loading ...

RedHill Presents Business Update at the Sachs' European Life Sciences CEO Forum

PR Newswire
·
27 Feb

RedHill Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties

PR Newswire
·
25 Feb

RedHill Biopharma Begins Phase 2 Study of Opaganib, Darolutamide for Advanced Prostate Cancer; Shares Rise

MT Newswires Live
·
04 Feb

RedHill Biopharma begins Phase 2 study of prostate cancer combination

TIPRANKS
·
04 Feb

RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer

PR Newswire
·
04 Feb

RedHill's Talicia® Adds 8 Million Lives With Coverage by Humana®'s Part D Plan. Also, New Data Supporting Simplified Three-Times Daily Talicia Dosing Published

PR Newswire
·
21 Jan

RedHill Biopharma’s opaganib shows radioprotective activity in study

TIPRANKS
·
10 Dec 2024

Radioprotective Activity of RedHill's Opaganib for GI-ARS Confirmed in New RNCP/NIAID Study - Discussions Ongoing with U.S. Government on Advanced Development

PR Newswire
·
10 Dec 2024

RedHill Biopharma awarded judgement of approx $8M by NY Supreme Court

TipRanks
·
03 Dec 2024

RedHill Biopharma Awarded $8 Million in Legal Case Against Kukbo

MT Newswires Live
·
02 Dec 2024

RedHill Biopharma Awarded Judgment of Approximately $8 Million Plus Costs by New York Supreme Court

PR Newswire
·
02 Dec 2024

RedHill Biopharma to Present Opaganib at U.S. Defense Conference

TIPRANKS
·
28 Oct 2024

RedHill Biopharma and Duke Collaborate on Opaganib Development

TipRanks
·
23 Oct 2024

RedHill Announces Collaboration with a Leading U.S. Academic Medical Center to Develop Opaganib as a Countermeasure Against Phosgene Inhalation Injury

PR Newswire
·
22 Oct 2024

RedHill Biopharma Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment

PR Newswire
·
14 Oct 2024

RedHill Biopharma Secures Opaganib COVID-19 Patent

TipRanks
·
01 Oct 2024